Skip to content
Open access

Role of CircRNA_0005075 in gastric cancer immune evasion through regulation of lactate metabolic reprogramming and histone lactylation

Sep 2026 · Translational Oncology · Vol 73, pp. 103037 · 0 citations · 48 references
Medicine

TL;DR

circRNA_0005075 knockdown potentiates anti-PD-1 therapy in vivo, suggesting a therapeutic target for gastric cancer.

Abstract

Highlights • circRNA_0005075 drives histone lactylation via lactate metabolism, establishing a novel metabolic-epigenetic-immune axis in gastric cancer.• circRNA_0005075 knockdown reduces H3K9la at PD-L1 promoter, suppressing PD-L1 and enhancing T cell cytotoxicity.• circRNA_0005075 knockdown potentiates anti-PD-1 therapy in vivo, suggesting a therapeutic target for gastric cancer.

Read PDF

Similar papers

Sep 2026

METTL15-mediated m4C modification regulates glucose metabolic reprogramming via c-Myc-dependent mechanisms and promotes hepatocellular carcinoma progression.

Although aerobic glycolysis is a hallmark of hepatocellular carcinoma (HCC) progression, the underlying epitranscriptomic mechanisms remain poorly understood. Here, we identify METTL15, an N4-methylcytidine (m4C) RNA methyltransferase, as a novel oncogenic driver of this metabolic reprogramming. METTL15 is significantl...

Longhui Xie, Ken Ning, Yu-Hu Wang et al. · 0 citations
Open access Sep 2026

WDR12 Promotes Glucose Metabolism via PFKFB4 Upregulation in Gastric Cancer

ABSTRACT Metabolic reprogramming is a hallmark of gastric cancer (GC); however, the role of transcriptional regulators in modulating glycolysis remains incompletely understood. By integrating proteomic, transcriptomic, and CRISPR‐based functional screening datasets, we identified WDR12, a WD40‐family protein that is up...

Ru-Tong Zhang, De-Hua Liu, Xiao-Xi Feng et al. · 0 citations
Open access Sep 2026

A Study on the Regulation of PD-L1 Immune Escape by Gastric Cancer CAF Subsets Based on Metabolic Heterogeneity through Lactation Modification

High-glycolytic iCAFs in the gastric cancer tumor microenvironment exhibit significant metabolic heterogeneity and can secrete large amounts of lactate through the reverse Warburg effect, thus constructing an immunosuppressive microenvironment. Lactic acid is transported into tumor cells via MCT1 and regulates PD-L1 ex...

E. Zhang · 0 citations
Review Open access Oct 2026

Histone Lactylation in Cancer: Linking Hypoxia-Driven Metabolism to Epigenetic Regulation

Solid tumors are frequently characterized by hypoxia, which drives metabolic reprogramming toward glycolysis and increased lactate production. Beyond its role as a metabolic end product, lactate can influence gene regulation through histone lactylation, a recently identified post-translational modification linking cell...

Julia Ostapowicz, K. Kulcenty · 0 citations
Open access Sep 2026

Histone H3K18 Lactylation Drives Immunosuppression by Upregulating CD38 in Myeloid-Derived Suppressor Cells in Lung Cancer.

Histone lactylation is an epigenetic modification that connects lactate metabolism with protein function. Our study identified lactate enhances the protein lactylation level not only in Myeloid-derived suppressor cells (MDSCs) of tumor-bearing mice, but also in the tumor tissues of lung cancer patients. This modificati...

Yao Dai, Hai-Yan Dai, Ya-Hui Wang et al. · 0 citations
Review Open access Sep 2026

Lactylation in gastric cancer: From mechanisms to clinical applications (Review)

Gastric cancer (GC) is one of the most common malignant tumors worldwide. Metabolic reprogramming and epigenetic dysregulation represent its key pathological characteristics. As a novel lactate-mediated post-translational modification, lactylation converts metabolic signals into epigenetic and protein functional regula...

Yu-Liang Fang, Peng Chen, Yu-Hong Gao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.